Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04669301 · ClinicalTrials.gov registry record · NA
Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II
A NA study of Cognitive Impairment and Cancer-related Problem/Condition, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT04669301 is a NA study of Cognitive Impairment and Cancer-related Problem/Condition that has completed, run by University of Rochester. The registered enrollment target is 72 participants, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04669301, a NA study of Cognitive Impairment and Cancer-related Problem/Condition, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
Cancer-related cognitive dysfunction (CRCD) affects up to 75% of patients receiving chemotherapy and older adults are at greater risk of developing CRCD, which can negatively affect their functional independence and quality of life. Memory and Attention Adaptation Training (MAAT) is a promising treatment for CRCD that improves perceived cognition in younger cancer survivors, but needs to be adapted for older adults to address their unique needs. The proposed study will adapt MAAT for older adults using feedback from key stakeholders (older adults with cancer and their caregivers), and subsequently test the ability of MAAT to improve or maintain cognition for older adults with breast cancer receiving adjuvant chemotherapy.
Conditions Studied
Interventions
- BEHAVIORAL MAAT-G
- BEHAVIORAL Supportive therapy (time and attention control)
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2021-04-02 |
| Est. Completion | 2024-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04669301
The ClinicalTrials.gov registry entry for NCT04669301 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (89% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which MAAT-G is the first listed.
NCT04669301 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04669301 about?
NCT04669301 is a clinical study titled "Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II". Cancer-related cognitive dysfunction (CRCD) affects up to 75% of patients receiving chemotherapy and older adults are at greater risk of developing CRCD, which can negatively affect their functional independence and quality of life. Memory and Attention Adaptation Training (MAAT) is a promising trea...
What is the current status of trial NCT04669301?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2021-04-02. Estimated completion is 2024-08-30.
What conditions does trial NCT04669301 study?
This clinical trial studies the following conditions: Cognitive Impairment, Cancer-related Problem/Condition.
What interventions are being tested in trial NCT04669301?
The interventions under investigation include: MAAT-G (BEHAVIORAL), Supportive therapy (time and attention control) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04669301?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04669301 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Mind Your Heart-II
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
RECRUITING · NA
-
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.